Recently adopted names for antitumoral compounds (December 2012) - Noms d’antitumoraux adoptés récemment (décembre 2012)

Name (nom)	Code name	Type	Target(s)
Dalantercept	ACE-041	Soluble fusion protein	Activin receptor-like kinase-1  ligands
Palifosfamide tromethamine	ZIO-201, Zymafos (commercial name)	Alkylating agent	DNA
Regorafenib	BAY 73-4506, Stivarga (commercial name)	Small multi-kinases inhibitor	RET, VEGFR1, VEGFR2, VEGFR3, KIT, PDGFR-α, PDGFR-β, FGFR1, FGFR2, TIE2, DDR2, Trk2A, Eph2A, RAF-1, BRAF, BRAFV600E , SAPK2, PTK5, and Abl